Patents by Inventor Jeffery M. Kramer

Jeffery M. Kramer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240307689
    Abstract: An example system includes electrical stimulation circuitry configured to generate electrical stimulation, electrodes configured to deliver the electrical stimulation to a patient, and processing circuitry configured to determine, for a patient, a first cycling of electric stimulation doses. The processing circuitry is also configured to deliver the electric stimulation doses according the determined first cycling, receive patient feedback representing a response of the patient to the electric stimulation doses delivered according to the first cycling, determine, based on the patient feedback, a second cycling of the electric stimulation doses, and deliver the electric stimulation doses to the patient according the determined second cycling. Delivering the electric stimulation doses for the patient according to the determined second cycling consumes less power of the implanted device than delivering the electric stimulation doses for the patient according to the determined first cycling.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 19, 2024
    Inventors: Vinod Sharma, Andrew J. Cleland, Nathan A. Torgerson, Benjamin P. Isaacson, Jeffery M. Kramer, Juan G. Hincapie, Brooke G. Kelley, Leonid M. Litvak, Paula Andrea Elma Dassbach Green, Michelle A. Case
  • Publication number: 20240293676
    Abstract: Systems, devices, and techniques are described for analyzing evoked compound action potential (ECAP) signals to determine an estimated neural threshold of a patient. In one example, a method includes controlling, by processing circuitry, delivery of a plurality of stimulation pulses to a patient, wherein each stimulation pulse of the plurality of stimulation pulses is at least partially defined by a different respective value of a stimulation parameter; receiving, by the processing circuitry, ECAP signal information, wherein the ECAP signal information comprises ECAP signals sensed by sensing circuitry and elicited by the plurality of stimulation pulses; determining, by the processing circuitry and based on the ECAP signal information, ECAP characteristic values for each of the ECAP signals elicited by the plurality' of stimulation pulses; and determining, by the processing circuitry and based on the ECAP characteristic values, an estimated neural threshold of the patient.
    Type: Application
    Filed: January 7, 2022
    Publication date: September 5, 2024
    Inventors: Leonid M. Litvak, David A. Dinsmoor, Juan G. Hincapie, Jeffery M. Kramer, Jerel K. Mueller, Joshua J. Nedrud, Malgorzata M. Straka
  • Publication number: 20240238592
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: February 6, 2024
    Publication date: July 18, 2024
    Inventors: Eyad Kishawi, Mir. A. Imran, Brian J. Mossap, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20240139521
    Abstract: Devices, systems, and techniques are configured for independently modulating two or more concurrent signals of electrical stimulation therapy. In one example, a system includes stimulation generation circuitry and processing circuitry configured to control the stimulation generation circuitry to deliver first electrical stimulation to a patient via a first electrode combination, wherein the first electrical stimulation is defined by at least a first set of stimulation parameters selected that the first electrical stimulation exceeds a first perception threshold, and control the stimulation generation circuitry to deliver second electrical stimulation, concurrent with the first electrical stimulation, to the patient via a second electrode combination. The second electrical stimulation may be defined by at least a second set of stimulation parameters selected that the second electrical stimulation is below a second perception threshold.
    Type: Application
    Filed: February 22, 2022
    Publication date: May 2, 2024
    Inventors: David A. Dinsmoor, Leonid M. Litvak, Jeffery M. Kramer
  • Patent number: 11890472
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: February 6, 2024
    Assignee: TC1 LLC
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20230381522
    Abstract: This disclosure is directed to devices, systems, and techniques for delivering various stimulation patterns. In some examples, a method includes generating, by stimulation generation circuitry, a first train of electrical stimulation pulses at a first frequency to a first target tissue, and generating, by the stimulation generation circuitry, a second train of electrical stimulation pulses at a second frequency to a second target tissue different from the first target tissue, wherein at least some electrical stimulation pulses of the first train of electrical stimulation pulses are interleaved with at least some electrical stimulation pulses of the second train of electrical stimulation pulses, and wherein the first frequency is greater than the second frequency.
    Type: Application
    Filed: October 8, 2021
    Publication date: November 30, 2023
    Inventors: Andrew J. Cleland, Brooke G. Kelley, Juan G. Hincapie, Vinod Sharma, Jeffery M. Kramer
  • Publication number: 20230355983
    Abstract: Techniques to provide haptic feedback to a patient to help the patient align a medical device to a location on their anatomy. In some examples, the patient may align a recharging device to a medical device that is implanted at the location on their anatomy. In some examples, the electrical stimulation can be delivered in such a way that the patient may or may not be able to feel the electrical stimulation, e.g., experience a paresthesia sensation. The system of this disclosure may intentionally adjust the stimulation intensity to provide patient feedback for alignment, such as alignment of the recharging device with the implanted device. Alignment of the recharging device with the implanted device may improve energy transfer, which may, for example, recharge the implanted device more efficiently.
    Type: Application
    Filed: May 3, 2023
    Publication date: November 9, 2023
    Inventors: Brian A. Smith, Jeffery M. Kramer, Andrew L. Schmeling, Andrew T. Fried, Todd D. Zenisek
  • Patent number: 11660452
    Abstract: In one embodiment, the present disclosure is directed to a method for providing a neural stimulation therapy to treat chronic pain of a patient. The method comprises: recording, using a neural sensing system, neural activity of the patient at one or more sites within the nervous system of the patient related to the chronic pain of the patient, modifying a computational neural modeling system to model the sensed neural activity of the patient; computing a respective neural response of the patient for each of a plurality of different temporal stimulation patterns using the modified computational neural modeling system; selecting, based on the respective neural responses, one of the plurality of temporal stimulation patterns; and programming an implantable stimulation system to provide the selected one of the plurality of temporal stimulation patterns to the patient to treat the chronic pain of the patient.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: May 30, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Alexander Kent, Jeffery M. Kramer
  • Publication number: 20220266029
    Abstract: An example method of delivering electrical stimulation includes obtaining, by an implantable medical device (IMD) connected to a lead carrying a plurality of electrodes, one or more stimulation parameters; and delivering, by the IMD and based on the one or more stimulation parameters, electrical stimulation therapy via the plurality of electrodes, wherein delivering the electrical stimulation therapy comprises scanning delivery of the electrical stimulation therapy through different pairs of electrodes of the plurality of electrodes.
    Type: Application
    Filed: February 23, 2022
    Publication date: August 25, 2022
    Inventors: Jeffery M. Kramer, Andrew J. Cleland, Leonid M. Litvak
  • Publication number: 20220152393
    Abstract: In one embodiment, the present disclosure is directed to a method for providing a neural stimulation therapy to treat chronic pain of a patient. The method comprises: recording, using a neural sensing system, neural activity of the patient at one or more sites within the nervous system of the patient related to the chronic pain of the patient, modifying a computational neural modeling system to model the sensed neural activity of the patient; computing a respective neural response of the patient for each of a plurality of different temporal stimulation patterns using the modified computational neural modeling system; selecting, based on the respective neural responses, one of the plurality of temporal stimulation patterns; and programming an implantable stimulation system to provide the selected one of the plurality of temporal stimulation patterns to the patient to treat the chronic pain of the patient.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Inventors: Alexander Kent, Jeffery M. Kramer
  • Publication number: 20210093866
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 1, 2021
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Publication number: 20200046981
    Abstract: Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
    Type: Application
    Filed: March 18, 2019
    Publication date: February 13, 2020
    Inventors: Jeffery M. KRAMER, Daniel H. KIM, Mir A. IMRAN
  • Publication number: 20190262610
    Abstract: In one embodiment, the present disclosure is directed to a method for providing a neural stimulation therapy to treat chronic pain of a patient. The method comprises: recording, using a neural sensing system, neural activity of the patient at one or more sites within the nervous system of the patient related to the chronic pain of the patient, modifying a computational neural modeling system to model the sensed neural activity of the patient; computing a respective neural response of the patient for each of a plurality of different temporal stimulation patterns using the modified computational neural modeling system; selecting, based on the respective neural responses, one of the plurality of temporal stimulation patterns; and programming an implantable stimulation system to provide the selected one of the plurality of temporal stimulation patterns to the patient to treat the chronic pain of the patient.
    Type: Application
    Filed: February 26, 2018
    Publication date: August 29, 2019
    Inventors: Alexander Kent, Jeffery M. Kramer
  • Patent number: 10232180
    Abstract: Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: March 19, 2019
    Assignees: The Board of Trustees of the Leland Stanford Junior University, St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)
    Inventors: Jeffery M. Kramer, Daniel H. Kim, Mir A. Imran
  • Publication number: 20190054300
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 21, 2019
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Patent number: 10105541
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 23, 2018
    Assignee: St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor
  • Publication number: 20180126166
    Abstract: Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
    Type: Application
    Filed: January 3, 2018
    Publication date: May 10, 2018
    Inventors: Jeffery M. KRAMER, Daniel H. KIM, Mir A. IMRAN
  • Publication number: 20170354822
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Inventors: Eyad KISHAWI, Mir A. IMRAN, Brian J. MOSSOP, Jeffery M. KRAMER, Richard W. O'CONNOR
  • Publication number: 20170274212
    Abstract: Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
    Type: Application
    Filed: November 8, 2016
    Publication date: September 28, 2017
    Inventors: Jeffery M. KRAMER, Daniel H. KIM, Mir A. IMRAN
  • Patent number: 9744360
    Abstract: Devices, systems and methods are provided for targeted treatment of a variety of conditions, particularly conditions that are associated with or influenced by the nervous system, such as pain. Targeted treatment of such conditions is provided with minimal deleterious side effects, such as undesired motor responses or undesired stimulation of unaffected body regions. This is achieved by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: August 29, 2017
    Assignee: St. Jude Medical Luxembourg Holdings SMI S.A.R.L.
    Inventors: Eyad Kishawi, Mir A. Imran, Brian J. Mossop, Jeffery M. Kramer, Richard W. O'Connor